Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Amiodarone market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Amiodarone market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Amiodarone market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Amiodarone products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Amiodarone products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Amiodarone market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Amiodarone development has been the leading industry trend of Amiodarone market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Amiodarone Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Tablet,Capsule,Injection, Other |
| By Application Outlook |
Cardiac Arrest,Ventricular Tachycardia,Atrial Fibrillation,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Sanofi,Sawai Pharmaceutical,Wyeth Pharmaceuticals (Pfizer),Mylan Pharmaceuticals,Arrow Pharma Pty Ltd,Roemmers,Cipla Pharmaceutical,Shanghai Pharmaceuticals,North China Pharmaceutical Company,Harbin Pharmaceutical Group |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Sanofi
- Sawai Pharmaceutical
- Wyeth Pharmaceuticals (Pfizer)
- Mylan Pharmaceuticals
- Arrow Pharma Pty Ltd
- Roemmers
- Cipla Pharmaceutical
- Shanghai Pharmaceuticals
- North China Pharmaceutical Company
- Harbin Pharmaceutical Group
Amiodarone Market, By Type
- Tablet
- Capsule
- Injection
- Other
Amiodarone Market, By Application
- Cardiac Arrest
- Ventricular Tachycardia
- Atrial Fibrillation
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Amiodarone Market Size Growth Rate by Type (2019-2025)
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Injection
1.4 Market Segment by Application
1.4.1 Global Amiodarone Market Share by Application (2019-2025)
1.4.2 Cardiac Arrest
1.4.3 Ventricular Tachycardia
1.4.4 Atrial Fibrillation
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amiodarone Market Size
2.1.1 Global Amiodarone Revenue 2014-2025
2.1.2 Global Amiodarone Sales 2014-2025
2.2 Amiodarone Growth Rate by Regions
2.2.1 Global Amiodarone Sales by Regions 2014-2019
2.2.2 Global Amiodarone Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Amiodarone Sales by Manufacturers
3.1.1 Amiodarone Sales by Manufacturers 2014-2019
3.1.2 Amiodarone Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Amiodarone Revenue by Manufacturers (2014-2019)
3.2.2 Amiodarone Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Amiodarone Market Concentration Ratio (CR5 and HHI)
3.3 Amiodarone Price by Manufacturers
3.4 Key Manufacturers Amiodarone Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Amiodarone Market
3.6 Key Manufacturers Amiodarone Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablet Sales and Revenue (2014-2019)
4.1.2 Capsule Sales and Revenue (2014-2019)
4.1.3 Injection Sales and Revenue (2014-2019)
4.2 Global Amiodarone Sales Market Share by Type
4.3 Global Amiodarone Revenue Market Share by Type
4.4 Amiodarone Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Amiodarone Sales by Application
6 United States
6.1 United States Amiodarone Breakdown Data by Company
6.2 United States Amiodarone Breakdown Data by Type
6.3 United States Amiodarone Breakdown Data by Application
7 European Union
7.1 European Union Amiodarone Breakdown Data by Company
7.2 European Union Amiodarone Breakdown Data by Type
7.3 European Union Amiodarone Breakdown Data by Application
8 China
8.1 China Amiodarone Breakdown Data by Company
8.2 China Amiodarone Breakdown Data by Type
8.3 China Amiodarone Breakdown Data by Application
9 Rest of World
9.1 Rest of World Amiodarone Breakdown Data by Company
9.2 Rest of World Amiodarone Breakdown Data by Type
9.3 Rest of World Amiodarone Breakdown Data by Application
9.4 Rest of World Amiodarone Breakdown Data by Countries
9.4.1 Rest of World Amiodarone Sales by Countries
9.4.2 Rest of World Amiodarone Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Amiodarone
10.1.4 Amiodarone Product Introduction
10.1.5 Sanofi Recent Development
10.2 Sawai Pharmaceutical
10.2.1 Sawai Pharmaceutical Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Amiodarone
10.2.4 Amiodarone Product Introduction
10.2.5 Sawai Pharmaceutical Recent Development
10.3 Wyeth Pharmaceuticals (Pfizer)
10.3.1 Wyeth Pharmaceuticals (Pfizer) Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Amiodarone
10.3.4 Amiodarone Product Introduction
10.3.5 Wyeth Pharmaceuticals (Pfizer) Recent Development
10.4 Mylan Pharmaceuticals
10.4.1 Mylan Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Amiodarone
10.4.4 Amiodarone Product Introduction
10.4.5 Mylan Pharmaceuticals Recent Development
10.5 Arrow Pharma Pty Ltd
10.5.1 Arrow Pharma Pty Ltd Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Amiodarone
10.5.4 Amiodarone Product Introduction
10.5.5 Arrow Pharma Pty Ltd Recent Development
10.6 Roemmers
10.6.1 Roemmers Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Amiodarone
10.6.4 Amiodarone Product Introduction
10.6.5 Roemmers Recent Development
10.7 Cipla Pharmaceutical
10.7.1 Cipla Pharmaceutical Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Amiodarone
10.7.4 Amiodarone Product Introduction
10.7.5 Cipla Pharmaceutical Recent Development
10.8 Shanghai Pharmaceuticals
10.8.1 Shanghai Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Amiodarone
10.8.4 Amiodarone Product Introduction
10.8.5 Shanghai Pharmaceuticals Recent Development
10.9 North China Pharmaceutical Company
10.9.1 North China Pharmaceutical Company Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Amiodarone
10.9.4 Amiodarone Product Introduction
10.9.5 North China Pharmaceutical Company Recent Development
10.10 Harbin Pharmaceutical Group
10.10.1 Harbin Pharmaceutical Group Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Amiodarone
10.10.4 Amiodarone Product Introduction
10.10.5 Harbin Pharmaceutical Group Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Amiodarone Sales Channels
11.2.2 Amiodarone Distributors
11.3 Amiodarone Customers
12 Market Forecast
12.1 Global Amiodarone Sales and Revenue Forecast 2019-2025
12.2 Global Amiodarone Sales Forecast by Type
12.3 Global Amiodarone Sales Forecast by Application
12.4 Amiodarone Forecast by Regions
12.4.1 Global Amiodarone Sales Forecast by Regions 2019-2025
12.4.2 Global Amiodarone Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
